Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: A novel signature based on microvascular invasion predicts the recurrence of HCC

Fig. 4

Computed tomography scan revealed the patients with different RFS. a peritumoral enhancement: recurrence 3.2 months, external portion enhancing in the arterial phase (arrows). b nonsmooth tumor margin positive: recurrence 4.5 months, focal extranodular extension (arrows) in the venous phase. c The two-trait algorithm predictive of MVI (TTPVI) positive: recurrence 2.8 months, blue arrows show internal artery and lower image means noncontinuous hypoattenuating halos

Back to article page